Efficacy and safety of proactive treatment with twice-weekly topical Cal/BD foam in patients with plaque psoriasis undergoing HPA-axis testing: a PSO-LONG subgroup analysis.
Kim PappZygmunt AdamskiLyn GuentherMonika LiljedahlAgnieszka Miasik-PogodzinskaAnna Szponar-BojdaCharles LyndeTerri NuttMarie Holst MørchStephen TyringWilliam WerschlerAdam ReichNeil SadickIrina TurchinJean-Philippe LacourPublished in: The Journal of dermatological treatment (2021)
Efficacy of PAM with Cal/BD foam is maintained in patients with moderate-to-severe psoriasis, with no new safety signals.